We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$13.4B
AUM Growth
+$468M
Cap. Flow
-$459M
Cap. Flow %
-3.43%
Top 10 Hldgs %
22.28%
Holding
376
New
43
Increased
81
Reduced
134
Closed
31

Top Buys

Rank Stock Value
1
TLIS
Talis Biomedical Corporation Common Stock
TLIS
+$99.8M
2
HSIC icon
Henry Schein
HSIC
+$74.3M
3
VRM icon
Vroom Inc
VRM
+$65.6M
4
TWOU
2U Inc
TWOU
+$63.3M
5
RBA icon
RB Global
RBA
+$61.9M

Top Sells

Rank Stock Value
1
BEAT
BioTelemetry, Inc.
BEAT
+$283M
2
PINS icon
Pinterest
PINS
+$106M
3
OTRK
Ontrak
OTRK
+$63.3M
4
HBI
Hanesbrands
HBI
+$61.5M
5
SBH icon
Sally Beauty Holdings
SBH
+$60.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.42%
2 Industrials 23.08%
3 Technology 18.58%
4 Consumer Discretionary 13.71%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWONK icon
251
Liberty Media Series C
FWONK
$25.8B
$3.29M 0.02%
78,709
– –
PANW icon
252
Palo Alto Networks
PANW
$314B
$3.22M 0.02%
60,000
– –
GWW icon
253
W.W. Grainger
GWW
$61.1B
$3.01M 0.02%
+7,500
New +$2.9M
FNF icon
254
Fidelity National Financial
FNF
$12.9B
$3M 0.02%
76,805
– –
EVI icon
255
EVI Industries
EVI
$181M
$2.95M 0.02%
102,430
+18,530
+22% +$649K
AMSC icon
256
American Superconductor
AMSC
$1.5B
$2.94M 0.02%
155,000
-85,000
-35% -$2.1M
KLRS
257
Kalaris Therapeutics
KLRS
$93.7M
$2.92M 0.02%
5,435
– –
ENPC
258
DELISTED
Executive Network Partnering Corporation
ENPC
$2.92M 0.02%
+299,994
New +$3.01M
MUSA icon
259
Murphy USA
MUSA
$10.2B
$2.88M 0.02%
19,930
– –
NCSM icon
260
NCS Multistage Holdings
NCSM
$132M
$2.82M 0.02%
101,596
-158
-0.2% -$5.09K
PZZA icon
261
Papa John's
PZZA
$785M
$2.66M 0.02%
30,000
– –
KKR icon
262
KKR & Co
KKR
$93.2B
$2.64M 0.02%
54,100
– –
VRT icon
263
Vertiv
VRT
$104B
$2.56M 0.02%
+128,129
New +$2.59M
LEGN icon
264
Legend Biotech
LEGN
$4B
$2.55M 0.02%
87,821
-108,035
-55% -$2.95M
NGM
265
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2.42M 0.02%
+83,333
New +$2.33M
TSHA icon
266
Taysha Gene Therapies
TSHA
$1.83B
$2.35M 0.02%
115,723
-12,451
-10% -$337K
NXTC icon
267
NextCure
NXTC
$31.3M
$2.29M 0.02%
19,071
-40,709
-68% -$5.9M
UFS
268
DELISTED
DOMTAR CORPORATION (New)
UFS
$2.29M 0.02%
62,000
– –
LTC
269
LTC Properties
LTC
$2.12B
$2.19M 0.02%
52,500
– –
SPRB
270
Spruce Biosciences
SPRB
$127M
$2.13M 0.02%
1,707
– –
NGA
271
DELISTED
Northern Genesis Acquisition Corp.
NGA
$2.12M 0.02%
+130,000
New +$2.9M
BALL icon
272
Ball Corp
BALL
$16.6B
$2.12M 0.02%
25,000
– –
LYV icon
273
Live Nation Entertainment
LYV
$43B
$2.12M 0.02%
25,000
– –
NGAB.U
274
DELISTED
Northern Genesis Acquisition Corp. II Units, each consisting of one share of common stock and one-th
NGAB.U
$2.05M 0.02%
+200,000
New +$2.24M
VCKAU
275
DELISTED
Vickers Vantage Corp. I Unit
VCKAU
$2.02M 0.02%
+200,000
New +$2.05M
9 10
11
12 13

Similar funds

SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.76B AUM 26.04% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

ArrowMark Colorado Holdings's Q1 2021 Portfolio in Review

As of Q1 2021, ArrowMark Colorado Holdings held 376 positions worth $13.4B, up 3.6% from $12.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ArrowMark Colorado Holdings withdrew a net $459M in Q1 2021, closing 31 positions and reducing 134 holdings. Its most notable exit was BioTelemetry, Inc., an estimated $283M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.

Against the trend, ArrowMark Colorado Holdings opened a new position in Talis Biomedical Corporation Common Stock worth $77.1M.

  • ArrowMark Colorado Holdings's largest Q1 2021 buy was Talis Biomedical Corporation Common Stock: 400,131 shares worth $77.1M.
  • ArrowMark Colorado Holdings added most to Vroom Inc in Q1 2021, an estimated $65.6M increase.
  • ArrowMark Colorado Holdings's biggest Q1 2021 reduction was Pinterest, cutting an estimated $106M.
  • ArrowMark Colorado Holdings fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $283M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 22% of its $13.4B portfolio in Q1 2021.
  • ArrowMark Colorado Holdings opened 43 new positions and closed 31 in Q1 2021.
  • ArrowMark Colorado Holdings's portfolio value rose 3.6% quarter-over-quarter to $13.4B.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2021, filed 17 May 2021.